Page 1 - hypertension_newsletter4_Final
P. 1

REFLECTIONS
                                                                                                                Hypertension
     Hypertension Global Newsletter #4 2023





                  TABLE OF CONTENTS


                                                                The REFLECTIONS Hypertension Global Newsletter
            KEY ARTICLES                                        series draws on the expertise of international   Hypertension
                                                                physicians to summarize the latest clinical and
          EPIDEMIOLOGY                                          real-world evidence in the field of hypertension and
                                                                reflect on the clinical impact of these new data on
          Arterial hypertension in women: State of the          the management of patients with hypertension. This
          art and knowledge gaps. Chapman N, et al.             time we will focus on key articles in the broad topics
          Hypertension. 2023;80(6):1140-1149.
                                                                of 1) epidemiology, 2) pathophysiology, 3) treatment,
          Five-year outcomes of the Danish                      and 3) special populations. On behalf of the Scientific
          cardiovascular screening (DANCAVAS)                   Planning Committee (SPC), I invite you to interact
          trial. Lindholt JS, et al. N Engl J Med. 2022 Oct
          13;387(15):1385-1394.                                 with this newsletter through links to video summaries
                                                                of the articles and short video clinical perspectives
          PATHOPHYSIOLOGY                                       from our SPC, and delve into the articles through
                                                                hyperlinks for in-depth study.
          Arterial stiffness precedes hypertension and
          metabolic risks in youth: A review. Agbaje AO. J      Prof. Laurent (Chair)
          Hypertens. 2022 Oct 1;40(10):1887-1896.
                                                                SCIENTIFIC PLANNING COMMITTEE
          TREATMENT

          Chlorthalidone vs. hydrochlorothiazide for
          hypertension-cardiovascular events. Ishani A, et                Prof. Stéphane Laurent
          al. N Engl J Med. 2022 Dec 29;387(26):2401-2410.                (France)

          Benefit of treatment based on indapamide
          mostly combined with perindopril on mortality
          and cardiovascular outcomes: A pooled                           Prof. Diego Araiza
          analysis of four trials. Chalmers J, et al. J                   (Mexico)
          Hypertens. 2023 Apr 1;41(4):527-544.

          Cardiovascular outcomes in adults with
          hypertension with evening versus morning                        Prof. Adriana Camargo
          dosing of usual antihypertensives in the UK                     (Brazil)
          (TIME study): A prospective, randomised, open-
          label, blinded-endpoint clinical trial. Mackenzie
          IS, et al. Lancet. 2022 Oct 22;400(10361):1417-
          1425.                                                           Dr. Om Narayan
                                                                          (Australia)
          SPECIAL POPULATIONS

          Atrial fibrillation detection and management in                 Prof. Nqoba Tsabedze
          hypertension. Gawalko, A, Linz D. Hypertension.
          2023 Mar;80(3):523-533.                                         (South Africa)



             ADDITIONAL ARTICLES OF INTEREST                              Prof. Svetlana Villevalde
                                                                          (Russia)
   1   2   3   4   5   6